Christopher J. Longo, Ph.D.

Assistant Professor, Strategic Market Leadership and Health Services Management, DeGroote School of Business, McMaster University.

Dr. Longo holds a B.A. in Economics (York University), an M.Sc. in Physiology (University of Western Ontario, Faculty of Medicine and Dentistry), and received a Ph.D. from the University of Toronto Department of Health Policy, Management and Evaluation, Faculty of Medicine.

Dr. Longo has 16 years of industry experience in clinical research, economic evaluation, and market access strategies for pharmaceuticals. He has published both clinical and economic research in a number of therapeutic areas including: diabetes, cancer, sepsis, and central nervous system disorders. Dr. Longo's research interests include the economic evaluation of pharmaceuticals using administrative databases, the public/private mix in the financing of healthcare, and the evaluation of factors influencing patients' financial burden for health care services.

Dr. Longo has consulted with numerous provincial and federal agencies related to economic evaluation of pharmaceuticals including: the Canadian Co-ordinating Office for Health Technology Assessment, Cancer Care Ontario, and the National Cancer Institute of Canada. Dr. Longo was the past chair of Rx&D's (Canada's Research-Based Pharmaceutical Companies) Health Economic Working Group from 2002-2004. Dr. Longo has also acted as an expert advisor to a number of Rx&D committees between 1997-2005. Dr. Longo has undertaken reviews for the journal "Pharmacoeconomics".

Dr. Longo was involved in the following M-THAC projects as an M-THAC fellow:

• Out-of-pocket costs for cancer patients in Ontario

Contact Information:
E-Mail: cjlongo@mcmaster.ca